COMMUNIQUÉS West-GlobeNewswire

Houston VA Study Reports Increased Quantitative Monitoring with TwitchView®; Separate Study Shows Near-Zero Bias Versus Gold Standard Mechanomyography, Both Presented at ANESTHESIOLOGY® 2026
28/10/2026
SEATTLE, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Blink Anesthesia, maker of the TwitchView ® quantitative neuromuscular monitor, highlights two studies presented at ANESTHESIOLOGY ® 2026, the annual meeting of the American [...]
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
28/10/2026
MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a multinational biopharmaceutical company, today announced that it will report operating and financial results for the third quarter 2026 [...]
Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November
28/10/2026
New academic publication highlights the strong science behind oral Xanamem's brain cortisol-control mechanism SYDNEY, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that following [...]
Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion
28/10/2026
Sabrina Martucci Johnson, President and CEO, shares her perspective on the recent White House Executive Order and how Daré Bioscience’s growing commercial portfolio and clinical pipeline position the Company to address [...]
Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery
28/10/2026
LAS VEGAS, NV, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes, age-related disorders, and anti- [...]
Cannabix Technologies Evaluating Expansion into Breath-Based Health and Biomarker Market with Proprietary BCU “VOC” Platform
28/10/2026
VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing [...]
SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia
28/10/2026
- Reaching the Pre-Specified 80 th Event Triggers the Final Analysis of the Pivotal Phase 3 Trial - - Company to Report Topline Primary Endpoint Results this Quarter - NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- SELLAS [...]
Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis
28/10/2026
PALI-2108 is an investigational, gut-activated, once-daily oral PDE4 inhibitor prodrug designed for sustained exposure and anti-inflammatory activity with the potential to improve tolerability 29 of 30 planned U.S. [...]
RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum
28/10/2026
MOUNTAIN VIEW, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer
28/10/2026
IRVINE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced the appointment of Neera Clase as Chief Commercial Officer (CCO), effective Nov. 1, 2026. Ms. Clase has [...]
Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients
28/10/2026
Human Research Ethics Submission Deadline Nov ‘26 with Site Initiation Activities Followed by First Patient Screening Planned for Feb ‘27 MELBOURNE, Australia, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( [...]
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
28/10/2026
Company plans to explore botanical approval pathways before initiating a prescription drug development program WASHINGTON, Oct. 28, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “ [...]
Axogen, Inc. Reports Third Quarter 2026 Financial Results
28/10/2026
Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million ALACHUA and TAMPA, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative [...]
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
28/10/2026
REYKJAVIK, ICELAND (October 28, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
28/10/2026
REYKJAVIK, Iceland, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026
28/10/2026
Conference Call Scheduled for November 4, 2026, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S.-based, end-to- [...]
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
28/10/2026
Phase 2 study to be conducted in participants with active moderate to severe psoriatic arthritis Novartis conducting study under global exclusive development and commercialization license agreement with Monte Rosa Monte [...]
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
28/10/2026
Biotechnology Executive Brings Extensive Capital Markets, Financing, Corporate Strategy and Investor Relations Experience ROCKVILLE, Md., Oct. 28, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences, Inc. (“NovaBridge” or [...]
Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date
28/10/2026
RALEIGH, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its third quarter 2026 financial and [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum